title: Mechanisms of immune complex-mediated experimental glomerulonephritis: possible role of the balance between endogenous TNF and soluble TNF receptor type 2.
abstract: In an experimental model of immune-complex-mediated glomerulonephritis, mice excreted increased levels of urinary protein starting three days after the induction. Mice lacking the TNF receptor type 2 (TNFR2) were protected from early proteinuria and enhanced mortality. Analysis of the molecular basis of the mechanisms of glomerulonephritis revealed that naïve mice continuously excrete soluble TNF-neutralizing TNFR2 in urine. Mice kept in a specific pathogen-free environment did not go on to develop early proteinuria or enhanced mortality, following induction of glomerulonephritis. TNFR2-deficient mice were protected from early proteinuria and enhanced mortality only when housed conventionally. Mice producing human TNFR2 that can be activated by mouse TNF, in addition to mouse TNFR2, did not demonstrate enhanced susceptibility to the lethal effects of glomerulonephritis, indicating that pro-inflammatory signalling via TNFR2 does not account for a sensitizing effect. Finally, we suggest that the protective effect seen in mice lacking TNFR2 results rather from environment-induced attenuation by low dose bacterial endotoxins than from missing pro-inflammatory signalling via the TNFR2.
authors.affiliation: Department of Immunology, University of Regensburg, Regensburg, Germany.
authors.forename: Eva
authors.initials: E
authors.lastname: Pfeifer
authors.forename: Johannes
authors.initials: J
authors.lastname: Polz
authors.forename: Sybille
authors.initials: S
authors.lastname: Grieβl
authors.forename: Sven
authors.initials: S
authors.lastname: Mostböck
authors.forename: Thomas
authors.initials: T
authors.lastname: Hehlgans
authors.forename: Daniela N
authors.initials: DN
authors.lastname: Männel
mesh_terms: D000704:Analysis of Variance; D000818:Animals; D000906:Antibodies / Q000009:adverse effects; D000936:Antigen-Antibody Complex / Q000276:immunology* / Q000378:metabolism; D003404:Creatinine / Q000097:blood / Q000652:urine; D050533:Glomerular Basement Membrane / Q000276:immunology; D005921:Glomerulonephritis / Q000139:chemically induced / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007668:Kidney / Q000473:pathology*; D008070:Lipopolysaccharides / Q000276:immunology / Q000378:metabolism; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D011507:Proteinuria / Q000652:urine; D011817:Rabbits; D047889:Receptors, Tumor Necrosis Factor, Type II / Q000097:blood / Q000235:genetics / Q000276:immunology* / Q000652:urine; D014409:Tumor Necrosis Factor-alpha / Q000097:blood / Q000276:immunology* / Q000652:urine
chemical_list: D000906:Antibodies; D000936:Antigen-Antibody Complex; D008070:Lipopolysaccharides; D047889:Receptors, Tumor Necrosis Factor, Type II; D014409:Tumor Necrosis Factor-alpha; D003404:Creatinine